KOR

e-Article

The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis.
Document Type
Article
Source
Lupus. 2002, Vol. 11 Issue 7, p454-457. 4p.
Subject
*CYCLOSPORINE
*NEWBORN infants
*POLYMYOSITIS
*PREGNANCY
*SYSTEMIC lupus erythematosus
Language
ISSN
0961-2033
Abstract
The case of a woman affected by an overlap syndrome systemic lupus erythematosus/polymyositis (PM), who presented with active myositis at the start of the pregnancy, is reported. Therapy with cyclosporin, corticosteroids, hydroxychloroquine and high-dose intravenous immunoglobulin induced a progressive remission of clinical and laboratory signs of myositis. At 33 weeks of gestation, after a premature pre-term rupture of membrane, a male child was delivered. Although premature, and small for gestational age, he had a normal growth, and did not show any clinical sign suggestive of immune deficiency. Lymphocyte phenotypical and functional studies, as well as response to vaccination, were also normal. [ABSTRACT FROM AUTHOR]